Acusphere, Inc.

AI-700 study suggests ultrasound with AI-700 compares well to nuclear imaging

Published in Medical Imaging Business Week, July 29th, 2004

Acusphere, Inc., (ACUS) announced that data from its phase II clinical trials of AI-700 were the subject of two presentations at the annual scientific meeting of the American Society of Echocardiography held in San Diego, California.

One conclusion in particular from these presentations indicated that based upon AI-700's phase II results, stress myocardial perfusion echo with AI-700 performed well in a comparison with nuclear stress perfusion in patients being evaluated for coronary heart disease.

AI-700 is being developed to enhance ultrasound imaging for use in the detection of coronary heart disease, the number one killer of American men and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Imaging Business Week

Source: Medical Imaging Business Week (2004-07-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry